pharmaceuticals

Eli Lilly pulls PBS application for eczema drug

Exciting updates in rosacea management

Upadacitinib shows promise for papulopustular rosacea in pilot study

‘Major step forward’: TGA approves first pharmacological therapy for OSA

New consensus for JAKi use in AD

Oral JAKi improves phototherapy-induced repigmentation in vitiligo

New authority requirement adding to the PBS ‘clickfest’

Dupilumab for chronic spontaneous urticaria gets tick
